Answers are grounded in this paper and cite their sources.
Prospective cohort study shows dietary habits affect inflammatory bowel disease activity, indicating potential dietary interventions.
Background The impact of dietary habits on the course of Inflammatory Bowel Disease (IBD) is increasingly recognized. Data from North African populations remain limited. Methods We conducted a prospective single-center study including 160 adult patients with Crohn’s Disease (n = 92, 57.5%) or Ulcerative Colitis (n = 68, 42.5%) at our Hospital between January 2021 and October 2025. Dietary intake was assessed using a validated food frequency questionnaire (FFQ), allowing calculation of an anti-/pro-inflammatory diet score. Disease activity was evaluated using the Harvey-Bradshaw Index (HBI) or Mayo Score, C-reactive protein (CRP), and fecal calprotectin. Patients were followed longitudinally for 12 months to capture flares and treatment escalations. Multivariate analyses were adjusted for age, sex, smoking, BMI, vitamin D status, and ongoing therapy (including vedolizumab, infliximab, ustekinumab, or biosimilars). Results High consumption of ultra-processed foods was associated with increased clinical activity (OR = 2.18; 95% CI [1.22–3.89], p = 0.009) and higher fecal calprotectin (p = 0.007). Conversely, a diet rich in fiber, fruits/vegetables, and omega-3 was linked to reduced risk of flares at 12 months (OR = 0.54; 95% CI [0.31–0.93], p = 0.03). In patients with colonic Crohn’s Disease (n = 45), high intake of refined sugars doubled the risk of HBI>5 (70% vs 33%, p = 0.01). Associations remained significant after adjusting for ongoing therapy. A dose-response trend was observed: higher anti-inflammatory diet scores correlated with lower HBI and calprotectin levels. Conclusion In this cohort, dietary patterns significantly influenced IBD activity, with pronounced effects in specific subgroups. Adoption of an anti-inflammatory diet may represent a complementary strategy alongside standard therapy, warranting randomized interventional studies Conflict of interest: Mrs. Lasfar, Intissar: No conflict of interest Gharbi, Khalid: No conflict of interest Akka, Rachid: No conflict of interest
No takes yet. Share an insight, caveat, or question.
Lasfar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: